Evidence map›Paper›PMID 41816640›Full record

ArticleFrontiers in neuroanatomy2026

Search for marker proteins to assess blood-brain barrier development.

Yukari Shigemoto-Mogami, Kimiko Nakayama-Kitamura, Kaoru Sato

Abstract read
In one paragraph

Article in Frontiers in neuroanatomy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yukari Shigemoto-MogamiLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
Kimiko Nakayama-KitamuraLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.
Kaoru SatoLaboratory of Neuropharmacology, Division of Pharmacology, National Institute of Health Sciences, Kawasaki, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The blood-brain barrier (BBB) separates the central nervous system from the peripheral blood circulation, and performs various functions such as dictating central nervous system (CNS)-specific pharmacokinetics, and maintaining brain homeostasis. While previous studies have clarified the mechanisms underlying cerebrovascular network development, details regarding

Indexed as

blood–brain barrier (BBB)developmentmarkersmicrophysiological system (MPS)permeability

Identifiers

PMID41816640
PMCPMC12971911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.